PEOPLE - World Heart announces some management changes:
This article was originally published in Clinica
Executive Summary
Ontario, Canada-based pulsatile ventricular assist device provider World Heart has announced some management changes. Jal Jassawalla has been named president and CEO, effective immediately. Mr Jassawalla succeeds Roderick Bryden, who recently resigned. Piet Jansen has been appointed managing director of the firm's European business. Dr Jansen will also continue in his role as chief medical officer. John Marinchak has been named vice-president of marketing and sales. He joined World Heart in November 2003. Finally, Robert Corson, who joined the company in November 1997, has been promoted to vice-president of manufacturing, and will be based in the firm's Oakland facilities.
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.